Demonstrates Novel Combination of Beta Glucan and Interferon Gamma Results in Tumor Regression

PHILADELPHIA, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA - (November 21, 2024) - The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and lab have discovered a new approach to treating ovarian cancer that, in preclinical laboratory testing, shrinks tumors and improves survival rates while simultaneously making tumors more receptive to chemotherapy treatment. Their findings were published in The Journal of Experimental Medicine in the paper,